Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2006

Piva R, Pellegrino E, Mattioli M, Agnelli L, Lombardi L, Boccalatte F, et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116(12):3171-82.

Cannon M, Cesarman E, Boshoff C. KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood. 2006;107(1):277-84.

Chiu A, Chadburn A. Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer Treat Res. 2006;131:1-48.

Khandelwal A, Seilstad KH, Magro CM. Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case. J Cutan Pathol. 2006;33(3):256-9.

Rand JH, Arslan AA, Wu X-, Wein R, Mulholland J, Shah M, et al. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol. 2006;194(1):182-8.

Magro CM, A Crowson N, Morrison C, Merati K, Porcu P, E Wright D. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol. 2006;125(4):490-501.

Moscat J, Rennert P, Diaz-Meco MT. PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 2006;13(5):702-11.

Kellner D, Chen J, Richardson I, Seshan SV, Chaar ME, Vaughan ED, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol. 2006;176(2):806-12.

Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn. 2006;8(5):582-8.

Guasparri I, Wu H, Cesarman E. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep. 2006;7(1):114-9.